Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image
Article image
Article image
Article image
Article image
Article image
Article image

Arthritis drugs banned

NZPA-AP London Citing possibly lethal side-effects, the British Government is banning two powerful painkilling drugs that have been prescribed to arthritis sufferers for 20 years, the Department of Health and Social Services announced. The drugs tandacote and tanderil, which contain a chemical called oxyphenbutazone, are to be withdrawn from prescription counters by June 8, the Under-Secre-tary of Health, Mr Kenneth Clarke, said in a written statement to the House of Commons.

A department spokesman, Mr Martin Smith, said that

doctors had long known about the drugs’ side-effects but had felt the benefits outweighed the risks. British doctors registered 503 cases of severe sideeffects, including intestinal disorders and high blood pressure, since the drugs were introduced in 1964, said Mr Smith. In 131 cases, the drug was thought to have contributed to a patient’s death.

Britain had instructed the drugs’ Swiss manufacturer, Geigy Pharmaceuticals, to write to doctors and pharmacies to inform them that the drug was no longer available, he said.

Permanent link to this item

https://paperspast.natlib.govt.nz/newspapers/CHP19840518.2.73.2

Bibliographic details

Press, 18 May 1984, Page 7

Word Count
164

Arthritis drugs banned Press, 18 May 1984, Page 7

Arthritis drugs banned Press, 18 May 1984, Page 7

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert